Predictive Oncology Inc (POAI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.0600 -0.0300 (-2.75%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0600 unch (unch) 16:00 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -12,664 | -13,984 | -25,738 | -19,657 | -25,884 |
Depreciation Amortization | 696 | 725 | 4,663 | 4,479 | 2,271 |
Accounts receivable | -468 | 19 | 23 | -21 | 70 |
Accounts payable and accrued liabilities | -191 | 399 | -78 | -350 | -1,689 |
Other Working Capital | -915 | -780 | 867 | -1,194 | -1,213 |
Other Operating Activity | 2,568 | 1,837 | 7,893 | 4,535 | 14,187 |
Operating Cash Flow | $-10,975 | $-11,784 | $-12,371 | $-12,209 | $-12,258 |
Cash Flows From Investing Activities | |||||
PPE Investments | -10 | -22 | -420 | -910 | -105 |
Net Acquisitions | N/A | N/A | N/A | -9,590 | N/A |
Purchase Sale Intangibles | N/A | -26 | -56 | -52 | -62 |
Other Investing Activity | 0 | -26 | -56 | -107 | -62 |
Investing Cash Flow | $-10 | $-48 | $-476 | $-10,608 | $-168 |
Cash Flows From Financing Activities | |||||
Debt Issued | 275 | 365 | N/A | N/A | 2,762 |
Debt Repayment | N/A | N/A | N/A | -4,163 | -1,472 |
Common Stock Issued | 4,961 | N/A | 6,743 | 55,713 | 11,885 |
Common Stock Repurchased | N/A | -2 | -28 | -12 | N/A |
Other Financing Activity | -1,297 | -214 | 0 | -1,198 | -222 |
Financing Cash Flow | $3,939 | $149 | $6,715 | $50,341 | $12,953 |
Beginning Cash Position | 8,729 | 22,072 | 28,203 | 678 | 151 |
End Cash Position | 735 | 8,729 | 22,072 | 28,203 | 678 |
Net Cash Flow | $-7,994 | $-13,343 | $-6,131 | $27,524 | $528 |
Free Cash Flow | |||||
Operating Cash Flow | -10,975 | -11,784 | -12,371 | -12,209 | -12,258 |
Capital Expenditure | -10 | -22 | -420 | -910 | -298 |
Free Cash Flow | -10,984 | -11,806 | -12,791 | -13,119 | -12,556 |